Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastomaJing Cui, Zhuang Zhengping, Qi Zhang et al.|Neuro-Oncology|2019Cited by 72
Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinomaLin Fang, Junnian Zheng, Weiping Tian et al.|Pharmacological Research|2023Cited by 49
Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinomaChen Zhang, Junnian Zheng, Jing Chen et al.|Molecular Therapy — Oncolytics|2021Cited by 38
Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumorsLin Fang, Gang Wang, Sen Yuan et al.|Cell Death Discovery|2023Cited by 32
Oncolytic Adenovirus-Mediated Expression of CCL5 and IL12 Facilitates CA9-Targeting CAR-T Therapy Against Renal Cell CarcinomaLin Fang, Junnian Zheng, Weiping Tian et al.|SSRN Electronic Journal|2022Cited by 1